Cargando…
Large sample size and nonlinear sparse models outline epistatic effects in inflammatory bowel disease
BACKGROUND: Despite clear evidence of nonlinear interactions in the molecular architecture of polygenic diseases, linear models have so far appeared optimal in genotype-to-phenotype modeling. A key bottleneck for such modeling is that genetic data intrinsically suffers from underdetermination ([Form...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552306/ https://www.ncbi.nlm.nih.gov/pubmed/37798735 http://dx.doi.org/10.1186/s13059-023-03064-y |
_version_ | 1785115933499457536 |
---|---|
author | Verplaetse, Nora Passemiers, Antoine Arany, Adam Moreau, Yves Raimondi, Daniele |
author_facet | Verplaetse, Nora Passemiers, Antoine Arany, Adam Moreau, Yves Raimondi, Daniele |
author_sort | Verplaetse, Nora |
collection | PubMed |
description | BACKGROUND: Despite clear evidence of nonlinear interactions in the molecular architecture of polygenic diseases, linear models have so far appeared optimal in genotype-to-phenotype modeling. A key bottleneck for such modeling is that genetic data intrinsically suffers from underdetermination ([Formula: see text] ). Millions of variants are present in each individual while the collection of large, homogeneous cohorts is hindered by phenotype incidence, sequencing cost, and batch effects. RESULTS: We demonstrate that when we provide enough training data and control the complexity of nonlinear models, a neural network outperforms additive approaches in whole exome sequencing-based inflammatory bowel disease case–control prediction. To do so, we propose a biologically meaningful sparsified neural network architecture, providing empirical evidence for positive and negative epistatic effects present in the inflammatory bowel disease pathogenesis. CONCLUSIONS: In this paper, we show that underdetermination is likely a major driver for the apparent optimality of additive modeling in clinical genetics today. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13059-023-03064-y. |
format | Online Article Text |
id | pubmed-10552306 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-105523062023-10-06 Large sample size and nonlinear sparse models outline epistatic effects in inflammatory bowel disease Verplaetse, Nora Passemiers, Antoine Arany, Adam Moreau, Yves Raimondi, Daniele Genome Biol Research BACKGROUND: Despite clear evidence of nonlinear interactions in the molecular architecture of polygenic diseases, linear models have so far appeared optimal in genotype-to-phenotype modeling. A key bottleneck for such modeling is that genetic data intrinsically suffers from underdetermination ([Formula: see text] ). Millions of variants are present in each individual while the collection of large, homogeneous cohorts is hindered by phenotype incidence, sequencing cost, and batch effects. RESULTS: We demonstrate that when we provide enough training data and control the complexity of nonlinear models, a neural network outperforms additive approaches in whole exome sequencing-based inflammatory bowel disease case–control prediction. To do so, we propose a biologically meaningful sparsified neural network architecture, providing empirical evidence for positive and negative epistatic effects present in the inflammatory bowel disease pathogenesis. CONCLUSIONS: In this paper, we show that underdetermination is likely a major driver for the apparent optimality of additive modeling in clinical genetics today. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13059-023-03064-y. BioMed Central 2023-10-05 /pmc/articles/PMC10552306/ /pubmed/37798735 http://dx.doi.org/10.1186/s13059-023-03064-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Verplaetse, Nora Passemiers, Antoine Arany, Adam Moreau, Yves Raimondi, Daniele Large sample size and nonlinear sparse models outline epistatic effects in inflammatory bowel disease |
title | Large sample size and nonlinear sparse models outline epistatic effects in inflammatory bowel disease |
title_full | Large sample size and nonlinear sparse models outline epistatic effects in inflammatory bowel disease |
title_fullStr | Large sample size and nonlinear sparse models outline epistatic effects in inflammatory bowel disease |
title_full_unstemmed | Large sample size and nonlinear sparse models outline epistatic effects in inflammatory bowel disease |
title_short | Large sample size and nonlinear sparse models outline epistatic effects in inflammatory bowel disease |
title_sort | large sample size and nonlinear sparse models outline epistatic effects in inflammatory bowel disease |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552306/ https://www.ncbi.nlm.nih.gov/pubmed/37798735 http://dx.doi.org/10.1186/s13059-023-03064-y |
work_keys_str_mv | AT verplaetsenora largesamplesizeandnonlinearsparsemodelsoutlineepistaticeffectsininflammatoryboweldisease AT passemiersantoine largesamplesizeandnonlinearsparsemodelsoutlineepistaticeffectsininflammatoryboweldisease AT aranyadam largesamplesizeandnonlinearsparsemodelsoutlineepistaticeffectsininflammatoryboweldisease AT moreauyves largesamplesizeandnonlinearsparsemodelsoutlineepistaticeffectsininflammatoryboweldisease AT raimondidaniele largesamplesizeandnonlinearsparsemodelsoutlineepistaticeffectsininflammatoryboweldisease |